Financials Arabian International Healthcare Holding Company
Equities
9530
SA15H194KT19
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.55 SAR | -0.13% |
|
-2.16% | -3.26% |
06-09 | Tibbiyah Unit Wins SAR24 Million Ortho, Spine Consumables Contract | MT |
05-15 | Tibbiyah Unit Bags SAR24 Million Medical Devices Supply Contract | MT |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 742 | 788.6 |
Enterprise Value (EV) 1 | 1,170 | 1,235 |
P/E ratio | 28.8 x | 20.7 x |
Yield | 2.7% | - |
Capitalization / Revenue | 1.15 x | 0.98 x |
EV / Revenue | 1.82 x | 1.53 x |
EV / EBITDA | 20 x | 17.8 x |
EV / FCF | 28,675,724 x | -51,925,807 x |
FCF Yield | 0% | -0% |
Price to Book | 2.49 x | 2.57 x |
Nbr of stocks (in thousands) | 20,000 | 19,790 |
Reference price 2 | 37.10 | 39.85 |
Announcement Date | 05/04/23 | 14/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 697 | 818.7 | 618.5 | 642.7 | 806.9 |
EBITDA 1 | 67.88 | 137.9 | 84.74 | 58.57 | 69.29 |
EBIT 1 | 63.12 | 133.7 | 81.09 | 54.52 | 59.82 |
Operating Margin | 9.06% | 16.33% | 13.11% | 8.48% | 7.41% |
Earnings before Tax (EBT) 1 | 56.73 | 119.8 | 93.74 | 42.34 | 53.92 |
Net income 1 | 41.13 | 95.79 | 82.31 | 25.76 | 38.09 |
Net margin | 5.9% | 11.7% | 13.31% | 4.01% | 4.72% |
EPS 2 | 822.6 | 73.29 | 4.116 | 1.289 | 1.925 |
Free Cash Flow | - | 151.8 | 122.1 | 40.81 | -23.79 |
FCF margin | - | 18.54% | 19.74% | 6.35% | -2.95% |
FCF Conversion (EBITDA) | - | 110.09% | 144.11% | 69.67% | - |
FCF Conversion (Net income) | - | 158.48% | 148.37% | 158.43% | - |
Dividend per Share | - | 4.100 | 3.000 | 1.000 | - |
Announcement Date | 13/01/22 | 13/01/22 | 19/03/22 | 05/04/23 | 14/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | 522 | 376 | 275 | 428 | 446 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | 7.692 x | 2.727 x | 3.247 x | 7.311 x | 6.443 x |
Free Cash Flow | - | 152 | 122 | 40.8 | -23.8 |
ROE (net income / shareholders' equity) | - | 32% | 24.7% | 9.4% | 12.1% |
ROA (Net income/ Total Assets) | - | 6.3% | 4.34% | 2.77% | 2.66% |
Assets 1 | - | 1,521 | 1,897 | 929 | 1,431 |
Book Value Per Share 2 | 5,326 | 16.60 | 16.70 | 14.90 | 15.50 |
Cash Flow per Share 2 | 284.0 | 0.6600 | 0.5500 | 4.220 | 4.160 |
Capex 1 | 2.32 | 1.28 | 1.3 | 2.69 | 7.89 |
Capex / Sales | 0.33% | 0.16% | 0.21% | 0.42% | 0.98% |
Announcement Date | 13/01/22 | 13/01/22 | 19/03/22 | 05/04/23 | 14/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-3.26% | 206M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+2.02% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- 9530 Stock
- Financials Arabian International Healthcare Holding Company